Glycaemic improvements were maintained in Zucker diabetic fatty rats 3 weeks after treatment cessation even though they had gained body weight and were similar in mass to vehicle-treated controls, demonstrating that the tri-agonist delays T2D progression in rodent models of spontaneous diabetes
And heres the encouraging part: all those metabolic improvements you made on GLP-1sthe weight loss, better insulin sensitivity, improved hormone balancethose benefits often stick around and make managing your condition easier even on different medications
by the Deutsche Forschungsgemeinschaft (GR 3671/1-1a)
They also may suppress appetite, although not their intended use
These three work in harmony to combat oxidative stress, boost immunity, and promote cellular health
Therefore, it is suggested that in individuals with cirrhosis, metformin should not be discontinued, unless necessary, as this could increase mortality 53